1. Home
  2. /
  3. Availability
  4. /
  5. Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Description

This paper assesses the effectiveness and cost-effectiveness of revaccinating adolescents in a setting with intense transmission—Cape Town, South Africa.
TB vaccine theme
Availability
Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
South Africa
Timeline
2013
Target group
Adolescents
Vaccine
BCG revaccination
Type of protection of vaccine
Prevention of infection
Type of research
Modelling
Partners involved
Aeras, BMGF, WHO
Type of project
research

Resources

Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Contact

Joeri Buis
joeri.buis@kncvtbc.org
Click to copy link of this headerMenu